Exosome Diagnostic and Therapeutics Market Insights Video

According to Cognitive Market Research, the global Exosome Diagnostic and Therapeutic market size is USD 228.9 million in 2024. It will expand at a compound annual growth rate (CAGR) of 30.60% from 2024 to 2031.

• North America held the major market share for more than 40% of the global revenue with a market size of USD 91.56 million in 2024 and will grow at a compound annual growth rate (CAGR) of 28.8% from 2024 to 2031.
• Europe accounted for a market share of over 30% of the global revenue with a market size of USD 68.67 million.
• Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 52.65 million in 2024 and will grow at a compound annual growth rate (CAGR) of 32.6% from 2024 to 2031.
• Latin America had a market share for more than 5% of the global revenue with a market size of USD 11.45 million in 2024 and will grow at a compound annual growth rate (CAGR) of 30.0% from 2024 to 2031.
• Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 4.58 million in 2024 and will grow at a compound annual growth rate (CAGR) of 30.3% from 2024 to 2031.
• The significant Exosome Diagnostic and Therapeutic market segment by product type is Instruments.